Filing Flows

Filing Flows › Companies › Koru Medical Systems › Cash flow

Koru Medical Systems cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow$108K in Q2 2026 · $777K over twelve months

Operating cash flow$216K
Capital spending−$108K
Free cash flow+$108K
Cash / net income0.9×

Analysis

In Q2 2026, Koru Medical Systems generated $216K of operating cash flow and spent $108K on capital projects, leaving free cash flow of $108K. That is $597K more than in Q2 2025 (−$489K).

Over the twelve months to Jun 30, 2026, operating cash flow was $1.4M; the largest uses were capital spending ($614K), other investing ($527K), net borrowing (+) / repaid (−) ($122K); besides operations, cash came from other financing ($105K); the cash balance rose by $233K.

Operating cash flow was $216K against net income of $252K — 0.9× profit, less cash than reported earnings, worth checking against working capital. The largest differences: accrued liabilities −$2.4M, receivables +$717K, stock-based pay +$458K.

Free cash flow

Koru Medical Systems: free cash flow by quarterKoru Medical Systems: free cash flow by quarter−$2.0MQ3 2024$983KQ4 2024−$681KQ1 2025−$489KQ2 2025$13KQ3 2025$687KQ4 2025−$32KQ1 2026$108KQ2 2026
Operating cash flow less capital spending.
Koru Medical Systems: operating cash flow against capital spendingKoru Medical Systems: operating cash flow against capital spendingOperating cash flowCapital spending−$924K$1.1MQ3 2024$940K−$44KQ4 2024−$237K$443KQ1 2025−$460K$29KQ2 2025$65K$52KQ3 2025$1.1M$408KQ4 2025$15K$46KQ1 2026$216K$108KQ2 2026
Latest (Q2 2026): Operating cash flow $216K, Capital spending $108K.

Capital allocation, year by year

Koru Medical Systems: where the cash came from (up) and went (down), by fiscal yearKoru Medical Systems: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesCapital spendingFY2021: Operating cash flow −$4.3MFY2021: Net borrowing −$3KFY2021: Shares issued $1.3MFY2021: Asset sales $9KFY2021: Capital spending −$346K$1.3MFY2021FY2022: Operating cash flow −$5.4MFY2022: Net borrowing −$52KFY2022: Shares issued $407KFY2022: Capital spending −$2.8M$407KFY2022FY2023: Operating cash flow −$4.9MFY2023: Net borrowing −$100KFY2023: Capital spending −$783KFY2023FY2024: Operating cash flow −$320KFY2024: Net borrowing −$108KFY2024: Asset sales $8KFY2024: Capital spending −$1.3M$8KFY2024FY2025: Operating cash flow $462KFY2025: Net borrowing −$109KFY2025: Shares issued $186KFY2025: Asset sales $7KFY2025: Capital spending −$933K$655KFY2025
Over these 5 years operating cash flow totalled −$14.5M; the largest uses were operating cash flow ($14.9M) and capital spending ($6.1M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$8.3M
Debtnone
Net cash$8.3M

Koru Medical Systems funds itself: free cash flow was $777K over the last twelve months, with $8.3M of cash and investments and no debt on the balance sheet.

Where the cash came from and went

Koru Medical Systems: sources (+) and uses (−) of cash, Q2 2026Koru Medical Systems: sources (+) and uses (−) of cash, Q2 2026Cash drawn (+) / kept (−)$480KOther investing−$469KOperating cash flow$216KCapital spending−$108KOther financing−$81KNet borrowing (+) / repaid (−)−$38K
Koru Medical Systems: sources (+) and uses (−) of cash, TTM to Q2 2026Koru Medical Systems: sources (+) and uses (−) of cash, TTM to Q2 2026Operating cash flow$1.4MCapital spending−$614KOther investing−$527KCash drawn (+) / kept (−)−$233KNet borrowing (+) / repaid (−)−$122KOther financing$105K

From profit to cash

Koru Medical Systems: net income to operating cash flow, Q2 2026Koru Medical Systems: net income to operating cash flow, Q2 2026Net income$252KDepreciation & amortization$210KStock-based pay$458KReceivables$717KInventory−$35KPayables$277KAccrued liabilities−$2.4MEmployee-related liabilities$422KPrepaid and other assets$419KOperating cash flow$216K
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q1 202647814979
Q4 202549914794
Q3 2025469333106
Q2 202549883899
Q1 202555764685
Q4 2024579547105
Q3 20246210050112

Every quarter

QuarterOperating cash flowCapital spendingNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026$216K−$108K−$38K—$480K$108K
Q1 2026$15K−$46K−$29K—$104K−$32K
Q4 2025$1.1M−$408K−$27K$97K−$408K$687K
Q3 2025$65K−$52K−$28K—−$409K$13K
Q2 2025−$460K−$29K−$27K—$681K−$489K
Q1 2025−$237K−$443K−$27K—$845K−$681K
Q4 2024$940K$44K−$26K—−$775K$983K
Q3 2024−$924K−$1.1M−$28K—$1.7M−$2.0M

Koru Medical Systems: income statement and cash flow

Koru Medical Systems, Q2 2026: revenue $12.0M (+18% year over year), operating margin 5.2%. The chart follows the revenue to costs, profit and cash.

Koru Medical Systems: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.